These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 822857)

  • 1. [The effect of thyrotrophin releasing hormone versus placebo in combination with basic imipramine therapy of depressive patients].
    Benkert O; Lücke KH
    Arzneimittelforschung; 1976; 26(6):1162-4. PubMed ID: 822857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The influence of thyrotrophin-releasing hormone (TRH) on depression in the alcohol withdrawal syndrome (author's transl)].
    Loosen PT; Wilson IC; Lara PP; Prange AJ; Pettus C
    Arzneimittelforschung; 1976; 26(6):1164-6. PubMed ID: 822858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trazodone, a triazolopyridine derivative, in primary depressive disorder.
    Feighner JP
    J Clin Psychiatry; 1980 Jul; 41(7):250-5. PubMed ID: 6993447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
    March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH
    J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of endogenous depressions with thyrotropin-releasing hormone (TRH) under oral administration.
    Schmidt J
    Acta Psychiatr Scand; 1977 Feb; 55(2):142-6. PubMed ID: 402795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preliminary study of the action of thyrotropin releasing hormone (TRH) in depressive states].
    Deniker P; Ginestet D; Lôo H; Zarifian E; Cottereau MJ
    Ann Med Psychol (Paris); 1974 Feb; 1(2):249-55. PubMed ID: 4211567
    [No Abstract]   [Full Text] [Related]  

  • 7. A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Merideth CH; Feighner JP; Hendrickson G
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):73-7. PubMed ID: 6370981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mianserin in the treatment of depression in general practice.
    Murphy JE; Donald JF; Molla AL
    Practitioner; 1976 Jul; 217(1297):135-8. PubMed ID: 792861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Controlled double-blind study (SAMe-imipramine) in depressive syndromes].
    Mantero M; Pastorino P; Carolei A; Agnoli A
    Minerva Med; 1975 Nov; 66(78):4098-101. PubMed ID: 1103017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
    Cohn CK; Robinson DS; Roberts DL; Schwiderski UE; O'Brien K; Ieni JR
    J Clin Psychiatry; 1996; 57 Suppl 2():15-8. PubMed ID: 8626358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amoxapine, imipramine and placebo in depressive illness.
    Smith RC
    Curr Ther Res Clin Exp; 1975 Aug; 18(2):346-53. PubMed ID: 809247
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthetic thyroid releasing hormone (TRH) administered orally to chronic schizophrenic patients.
    Clark ML; Paredes A; Costiloe JP; Wood F
    Psychopharmacol Commun; 1975; 1(2):191-200. PubMed ID: 817373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyprolidol and imipramine: a double-blind controlled study in endogenous depression.
    Hekimian LJ; Gershon S; Floyd A
    Arzneimittelforschung; 1969 Jun; 19(6):955-6. PubMed ID: 4896165
    [No Abstract]   [Full Text] [Related]  

  • 15. A placebo- and imipramine-controlled study of paroxetine.
    Cohn JB; Crowder JE; Wilcox CS; Ryan PJ
    Psychopharmacol Bull; 1990; 26(2):185-9. PubMed ID: 2146697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-center double-blind study of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Cohn JB; Varga L; Lyford A
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):68-72. PubMed ID: 6370980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amoxapine and imipramine: a double-blind study in depressed patients.
    Sathananthan GL; Matz R; Thompson H; Gershon S
    Curr Ther Res Clin Exp; 1973 Dec; 15(12):919-22. PubMed ID: 4203576
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of imipramine in psychotic versus nonpsychotic depression.
    Birkenhager TK; van den Broek WW; Mulder PG; Moleman P; Bruijn JA
    J Clin Psychopharmacol; 2008 Apr; 28(2):166-70. PubMed ID: 18344726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression associated with alcohol withdrawal. Imipramine therapy compared with placebo.
    Butterworth AT
    Q J Stud Alcohol; 1971 Jun; 32(2):343-8. PubMed ID: 4932253
    [No Abstract]   [Full Text] [Related]  

  • 20. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
    Stark P; Hardison CD
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.